Omar Bayomy1, Ajay D Rao1,2,3,4, Rajesh Garg1,2, Anand Vaidya1,2, Alyssa R Kotin2, Beata Reiber5, Stephanie Nijmeijer5, Marcelo F Di Carli1,5,6, Michael Jerosch-Herold1,5, Raymond Y Kwong1,6, Gail K Adler1,2. 1. 1 Harvard Medical School , Boston, Massachusetts. 2. 2 Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital , Boston, Massachusetts. 3. 3 Section of Endocrinology, Diabetes and Metabolism, Lewis Katz School of Medicine , Philadelphia, Pennsylvania. 4. 4 Center for Metabolic Disease Research, Lewis Katz School of Medicine , Philadelphia, Pennsylvania. 5. 5 Department of Radiology, Brigham and Women's Hospital , Boston, Massachusetts. 6. 6 Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital , Boston, Massachusetts.
Abstract
BACKGROUND:Plasminogen activator inhibitor-1 (PAI-1) is implicated in the pathophysiology of cardiovascular disease (CVD) and increased in individuals with type 2 diabetes mellitus (T2DM). Adipose tissue produces PAI-1, and pericardial fat is a CVD risk factor. We sought to determine the relationship between PAI-1 and pericardial fat in males and females with well-controlled T2DM. METHODS: The study population consisted of 32 males and 19 females, aged 35-70 years with T2DM, without clinical evidence of CVD or other active medical problems except for hypertension. Subjects were studied under good cardiometabolic control. Study procedures included fasting blood work and cardiovascular imaging. Cardiac magnetic resonance imaging of the heart was used to identify and quantify pericardial fat from the bifurcation of the pulmonary trunk to the last slice containing cardiac tissue. RESULTS: PAI-1 was positively correlated with pericardial fat (β = 0.72, r = 0.72, P < 0.001) as well as with homeostatic model assessment of insulin resistance (r = 0.31, P = 0.03) and serum triglycerides (r = 0.27, P = 0.05). In a multivariable regression model, controlling for insulin sensitivity, triglycerides, and body mass index, pericardial fat was independently associated with PAI-1 (β = 0.80, P < 0.001). CONCLUSIONS: PAI-1 is positively associated with pericardial fat in individuals with T2DM.
RCT Entities:
BACKGROUND:Plasminogen activator inhibitor-1 (PAI-1) is implicated in the pathophysiology of cardiovascular disease (CVD) and increased in individuals with type 2 diabetes mellitus (T2DM). Adipose tissue produces PAI-1, and pericardial fat is a CVD risk factor. We sought to determine the relationship between PAI-1 and pericardial fat in males and females with well-controlled T2DM. METHODS: The study population consisted of 32 males and 19 females, aged 35-70 years with T2DM, without clinical evidence of CVD or other active medical problems except for hypertension. Subjects were studied under good cardiometabolic control. Study procedures included fasting blood work and cardiovascular imaging. Cardiac magnetic resonance imaging of the heart was used to identify and quantify pericardial fat from the bifurcation of the pulmonary trunk to the last slice containing cardiac tissue. RESULTS:PAI-1 was positively correlated with pericardial fat (β = 0.72, r = 0.72, P < 0.001) as well as with homeostatic model assessment of insulin resistance (r = 0.31, P = 0.03) and serum triglycerides (r = 0.27, P = 0.05). In a multivariable regression model, controlling for insulin sensitivity, triglycerides, and body mass index, pericardial fat was independently associated with PAI-1 (β = 0.80, P < 0.001). CONCLUSIONS:PAI-1 is positively associated with pericardial fat in individuals with T2DM.
Authors: N J Brown; K S Kim; Y Q Chen; L S Blevins; J H Nadeau; S G Meranze; D E Vaughan Journal: J Clin Endocrinol Metab Date: 2000-01 Impact factor: 5.958
Authors: Amir A Mahabadi; Marie H Berg; Nils Lehmann; Hagen Kälsch; Marcus Bauer; Kaffer Kara; Nico Dragano; Susanne Moebus; Karl-Heinz Jöckel; Raimund Erbel; Stefan Möhlenkamp Journal: J Am Coll Cardiol Date: 2013-02-20 Impact factor: 24.094
Authors: Vanessa Xanthakis; Danielle M Enserro; Joanne M Murabito; Joseph F Polak; Kai C Wollert; James L Januzzi; Thomas J Wang; Geoffrey Tofler; Ramachandran S Vasan Journal: Circulation Date: 2014-10-01 Impact factor: 29.690
Authors: I Shimomura; T Funahashi; M Takahashi; K Maeda; K Kotani; T Nakamura; S Yamashita; M Miura; Y Fukuda; K Takemura; K Tokunaga; Y Matsuzawa Journal: Nat Med Date: 1996-07 Impact factor: 53.440
Authors: J Schneiderman; M S Sawdey; M R Keeton; G M Bordin; E F Bernstein; R B Dilley; D J Loskutoff Journal: Proc Natl Acad Sci U S A Date: 1992-08-01 Impact factor: 11.205
Authors: Caroline S Fox; Sherita Hill Golden; Cheryl Anderson; George A Bray; Lora E Burke; Ian H de Boer; Prakash Deedwania; Robert H Eckel; Abby G Ershow; Judith Fradkin; Silvio E Inzucchi; Mikhail Kosiborod; Robert G Nelson; Mahesh J Patel; Michael Pignone; Laurie Quinn; Philip R Schauer; Elizabeth Selvin; Dorothea K Vafiadis Journal: Circulation Date: 2015-08-05 Impact factor: 29.690